These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 25550394)

  • 21. Caspofungin in combination with amphotericin B against Candida glabrata.
    Barchiesi F; Spreghini E; Fothergill AW; Arzeni D; Greganti G; Giannini D; Rinaldi MG; Scalise G
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2546-9. PubMed ID: 15917570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of genetic markers of resistance to echinocandins, azoles and 5-fluorocytosine in Candida glabrata by next-generation sequencing: a feasibility study.
    Biswas C; Chen SC; Halliday C; Kennedy K; Playford EG; Marriott DJ; Slavin MA; Sorrell TC; Sintchenko V
    Clin Microbiol Infect; 2017 Sep; 23(9):676.e7-676.e10. PubMed ID: 28344162
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of Candida glabrata strains with reduced sensitivity to micafungin in vitro isolated from a patient with persistent Candidemia.
    Ishikawa T; Takata T; Akamatsu S; Hatakenaka K; Matsumoto S; Maki K; Ikeda F; Tamai R; Tamura K
    Jpn J Infect Dis; 2010 Sep; 63(5):332-7. PubMed ID: 20858999
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Successful treatment with caspofungin of an invasive candidosis resistant to liposomal amphotericin B in a neutropenic patient].
    Rome A; André N; Michel A; Coze C; Gentet JC; Bernard JL
    Arch Pediatr; 2006 Dec; 13(12):1556-7. PubMed ID: 17049216
    [No Abstract]   [Full Text] [Related]  

  • 25. Prevalence and antifungal susceptibility patterns of new cryptic species inside the species complexes Candida parapsilosis and Candida glabrata among blood isolates from a Spanish tertiary hospital.
    Miranda-Zapico I; Eraso E; Hernández-Almaraz JL; López-Soria LM; Carrillo-Muñoz AJ; Hernández-Molina JM; Quindós G
    J Antimicrob Chemother; 2011 Oct; 66(10):2315-22. PubMed ID: 21795259
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acquisition of flucytosine, azole, and caspofungin resistance in Candida glabrata bloodstream isolates serially obtained from a hematopoietic stem cell transplant recipient.
    Chapeland-Leclerc F; Hennequin C; Papon N; Noël T; Girard A; Socié G; Ribaud P; Lacroix C
    Antimicrob Agents Chemother; 2010 Mar; 54(3):1360-2. PubMed ID: 20038613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Successful treatment of liposomal amphotericin B refractory Candida glabrata fungaemia in a patient undergoing a stem cell transplantation.
    Veldman BA; Verweij PE; Blijlevens NM
    Neth J Med; 2006 Apr; 64(4):127-9. PubMed ID: 16609161
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emergence of resistance to amphotericin B and triazoles in Candida glabrata vaginal isolates in a case of recurrent vaginitis.
    Khan ZU; Ahmad S; Al-Obaid I; Al-Sweih NA; Joseph L; Farhat D
    J Chemother; 2008 Aug; 20(4):488-91. PubMed ID: 18676230
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fungicidal activity of the human peptide hepcidin 20 alone or in combination with other antifungals against Candida glabrata isolates.
    Tavanti A; Maisetta G; Del Gaudio G; Petruzzelli R; Sanguinetti M; Batoni G; Senesi S
    Peptides; 2011 Dec; 32(12):2484-7. PubMed ID: 22015266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tipping the balance both ways: drug resistance and virulence in Candida glabrata.
    Vale-Silva LA; Sanglard D
    FEMS Yeast Res; 2015 Jun; 15(4):fov025. PubMed ID: 25979690
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of Candida parapsilosis Sensu Lato in Pediatric Patients and Antifungal Susceptibility Testing.
    Cattana ME; Dudiuk C; Fernández M; Rojas F; Alegre L; Córdoba S; Garcia-Effron G; Giusiano G
    Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28483957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Initial Treatment of Cancer Patients with Fluconazole-Susceptible Dose-Dependent Candida glabrata Fungemia: Better Outcome with an Echinocandin or Polyene Compared to an Azole?
    Le A; Farmakiotis D; Tarrand JJ; Kontoyiannis DP
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584138
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FKS mutant Candida glabrata: risk factors and outcomes in patients with candidemia.
    Beyda ND; John J; Kilic A; Alam MJ; Lasco TM; Garey KW
    Clin Infect Dis; 2014 Sep; 59(6):819-25. PubMed ID: 24879785
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resistance of Candida to azoles and echinocandins worldwide.
    Pristov KE; Ghannoum MA
    Clin Microbiol Infect; 2019 Jul; 25(7):792-798. PubMed ID: 30965100
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activity of amphotericin B, anidulafungin, caspofungin, micafungin, posaconazole, and voriconazole against Candida albicans with decreased susceptibility to fluconazole from APECED patients on long-term azole treatment of chronic mucocutaneous candidiasis.
    Rautemaa R; Richardson M; Pfaller MA; Perheentupa J; Saxén H
    Diagn Microbiol Infect Dis; 2008 Oct; 62(2):182-5. PubMed ID: 18597968
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Species distribution and drug susceptibilities of Candida isolates in TSARY 2010.
    Yang YL; Chen HT; Lin CC; Chu WL; Lo HJ;
    Diagn Microbiol Infect Dis; 2013 Jun; 76(2):182-6. PubMed ID: 23574935
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antifungal resistance does not necessarily affect Candida glabrata fitness.
    Borghi E; Andreoni S; Cirasola D; Ricucci V; Sciota R; Morace G
    J Chemother; 2014 Feb; 26(1):32-6. PubMed ID: 24091025
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antifungal drugs.
    Treat Guidel Med Lett; 2008 Jan; 6(65):1-8. PubMed ID: 18157085
    [No Abstract]   [Full Text] [Related]  

  • 39. Isolation of cholesterol-dependent, multidrug-resistant Candida glabrata strains from blood cultures of a candidemia patient in Kuwait.
    Khan Z; Ahmad S; Joseph L; Al-Obaid K
    BMC Infect Dis; 2014 Apr; 14():188. PubMed ID: 24712485
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Profiling of
    Hou X; Xiao M; Wang H; Yu SY; Zhang G; Zhao Y; Xu YC
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29581110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.